Last Chance: How GLP-1 Is Reshaping Fitness—What It Means for You

Last Chance: How GLP-1 Is Reshaping Fitness—What It Means for You

Join Fitness Industry Canada on May 21 at 1:00 p.m. EDT for an in-depth webinar exploring one of the most significant shifts currently impacting the fitness industry: the rapid rise of GLP-1 medications and what they mean for coaching, programming, and long-term client success. With nearly 3 million Canadians now using medications such as Ozempic, Wegovy, and Mounjaro, fitness professionals are increasingly being called on to adapt their approach to support this growing population.

 

Featuring Dr. Ian Patton of Obesity Canada, the session will provide practical, science-based insights into how exercise, strength training, and behaviour support can complement GLP-1 therapies. Topics will include preserving lean muscle during weight loss, modifying training for clients experiencing side effects, and redefining the role of the coach as a long-term health partner rather than a short-term weight loss solution.

 

The webinar will also explore how fitness professionals can effectively collaborate with healthcare providers while staying within their scope of practice, reflecting the broader convergence of fitness, healthcare, and obesity management. As demand grows for informed, evidence-based guidance, this session offers a timely opportunity to better understand and respond to one of the fastest-evolving trends in the industry.

Stay Connected!

Subscribe to FitBizWeekly’s FREE newsletter for news, commentary, idea sharing and developments across the Canadian health and fitness industry.


By clicking on the Subscribe button you agree to be on our newsletter list. You can opt out anytime. We respect your privacy. Your information will not be shared and your email address will be stored safely. 

STAY TUNED

subscribe to our weekly newsletter